343 related articles for article (PubMed ID: 18482432)
1. The role of CB1 receptors in psychostimulant addiction.
Wiskerke J; Pattij T; Schoffelmeer AN; De Vries TJ
Addict Biol; 2008 Jun; 13(2):225-38. PubMed ID: 18482432
[TBL] [Abstract][Full Text] [Related]
2. Effects of the cannabinoid CB₁ receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats.
Jing L; Qiu Y; Zhang Y; Li JX
Drug Alcohol Depend; 2014 Oct; 143():251-6. PubMed ID: 25169627
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of endocannabinoid neurotransmission through CB1 cannabinoid receptors counteracts the reinforcing and psychostimulant effects of cocaine.
Vlachou S; Stamatopoulou F; Nomikos GG; Panagis G
Int J Neuropsychopharmacol; 2008 Nov; 11(7):905-23. PubMed ID: 18377702
[TBL] [Abstract][Full Text] [Related]
4. Cannabinoid CB1 receptors control conditioned drug seeking.
De Vries TJ; Schoffelmeer AN
Trends Pharmacol Sci; 2005 Aug; 26(8):420-6. PubMed ID: 15992935
[TBL] [Abstract][Full Text] [Related]
5. An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.
Fattore L; Spano MS; Deiana S; Melis V; Cossu G; Fadda P; Fratta W
Brain Res Rev; 2007 Jan; 53(1):1-16. PubMed ID: 16839608
[TBL] [Abstract][Full Text] [Related]
6. Drug addiction.
Justinova Z; Panlilio LV; Goldberg SR
Curr Top Behav Neurosci; 2009; 1():309-46. PubMed ID: 21104390
[TBL] [Abstract][Full Text] [Related]
7. Role of cannabinoid type 1 receptors in locomotor activity and striatal signaling in response to psychostimulants.
Corbillé AG; Valjent E; Marsicano G; Ledent C; Lutz B; Hervé D; Girault JA
J Neurosci; 2007 Jun; 27(26):6937-47. PubMed ID: 17596442
[TBL] [Abstract][Full Text] [Related]
8. Effects of cannabinoid CB₁ receptor antagonist rimonabant on acquisition and reinstatement of psychostimulant reward memory in mice.
Yu LL; Zhou SJ; Wang XY; Liu JF; Xue YX; Jiang W; Lu L
Behav Brain Res; 2011 Feb; 217(1):111-6. PubMed ID: 20937331
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the endocannabinoid system in drug addiction.
Maldonado R; Valverde O; Berrendero F
Trends Neurosci; 2006 Apr; 29(4):225-32. PubMed ID: 16483675
[TBL] [Abstract][Full Text] [Related]
10. The roles of cannabinoid CB1 and CB2 receptors in cocaine-induced behavioral sensitization and conditioned place preference in mice.
Lopes JB; Bastos JR; Costa RB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2020 Feb; 237(2):385-394. PubMed ID: 31667531
[TBL] [Abstract][Full Text] [Related]
11. The pharmacology of the endocannabinoid system: functional and structural interactions with other neurotransmitter systems and their repercussions in behavioral addiction.
López-Moreno JA; González-Cuevas G; Moreno G; Navarro M
Addict Biol; 2008 Jun; 13(2):160-87. PubMed ID: 18422831
[TBL] [Abstract][Full Text] [Related]
12. A cannabinoid mechanism in relapse to cocaine seeking.
De Vries TJ; Shaham Y; Homberg JR; Crombag H; Schuurman K; Dieben J; Vanderschuren LJ; Schoffelmeer AN
Nat Med; 2001 Oct; 7(10):1151-4. PubMed ID: 11590440
[TBL] [Abstract][Full Text] [Related]
13. The role of endocannabinoid transmission in cocaine addiction.
Arnold JC
Pharmacol Biochem Behav; 2005 Jun; 81(2):396-406. PubMed ID: 15925401
[TBL] [Abstract][Full Text] [Related]
14. Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies.
Le Foll B; Forget B; Aubin HJ; Goldberg SR
Addict Biol; 2008 Jun; 13(2):239-52. PubMed ID: 18482433
[TBL] [Abstract][Full Text] [Related]
15. Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core.
Schoffelmeer AN; Hogenboom F; Wardeh G; De Vries TJ
Neuropharmacology; 2006 Sep; 51(4):773-81. PubMed ID: 16806307
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade.
Anggadiredja K; Nakamichi M; Hiranita T; Tanaka H; Shoyama Y; Watanabe S; Yamamoto T
Neuropsychopharmacology; 2004 Aug; 29(8):1470-8. PubMed ID: 15085091
[TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1 receptor antagonism--or inverse agonism--as potential obesity treatment and other therapeutic use.
Xie S; Furjanic MA; Ferrara JJ; McAndrew NR; Ardino EL; Ngondara A; Bernstein Y; Thomas KJ; Kim E; Walker JM; Nagar S; Ward SJ; Raffa RB
J Clin Pharm Ther; 2007 Jun; 32(3):209-31. PubMed ID: 17489873
[TBL] [Abstract][Full Text] [Related]
18. Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior.
Duarte C; Alonso R; Bichet N; Cohen C; Soubrié P; Thiébot MH
Neuropsychopharmacology; 2004 May; 29(5):911-20. PubMed ID: 14694354
[TBL] [Abstract][Full Text] [Related]
19. Context-specific reversal of cocaine sensitization by the CB1 cannabinoid receptor antagonist rimonabant.
Gerdeman GL; Schechter JB; French ED
Neuropsychopharmacology; 2008 Oct; 33(11):2747-59. PubMed ID: 18059436
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cannabinoid CB1 receptors in drug addiction: effects of rimonabant on behavioral responses induced by cocaine.
Filip M; Gołda A; Zaniewska M; McCreary AC; Nowak E; Kolasiewicz W; Przegaliński E
Pharmacol Rep; 2006; 58(6):806-19. PubMed ID: 17220538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
